Related Experiment Video
Updated: May 2, 2026

10:57
Experimental Protocol for Detecting Cyanobacteria in Liquid and Solid Samples with an Antibody Microarray Chip
Published on: February 7, 2017
8.7K
Colorimetric engineered immunoprobe for the detection and quantification of microcystins
Larissa M Alvarenga1, Julien Muzard2, Aurélie Ledreux1
1Muséum national d'Histoire naturelle et Centre National de la Recherche Scientifique, UMR 7245, 57 rue Cuvier, 75231 Paris Cedex 05, France.
Journal of Immunological Methods
|March 11, 2014
Summary
Researchers developed a new detection method for microcystins (MCs), harmful cyanobacteria toxins, using a recombinant antibody fused to an enzyme. This approach offers a faster and more adaptable way to detect these dangerous toxins in water.
Area of Science:
- Environmental Science
- Biotechnology
- Analytical Chemistry
Background:
- Microcystins (MCs) are potent heptapeptide toxins produced by cyanobacteria, posing a global threat to aquatic ecosystems and human health.
- Existing detection methods for MCs, including antibody-based assays, face challenges in specificity, efficiency, and adaptability for field use.
Purpose of the Study:
- To develop a novel, highly specific, and efficient detection method for microcystins using recombinant antibody technology.
- To create a bivalent colorimetric immunoprobe (scFv-AP) for direct competitive enzyme immunoassay (ELISA) of MCs.
Main Methods:
- Production of a recombinant antibody fragment (single-chain variable fragment, scFv) fused to alkaline phosphatase (AP) from Escherichia coli.
- Expression of the scFv-AP fusion protein in the periplasm of recombinant bacteria for direct use without purification.
- Development of a direct competitive enzyme immunoassay utilizing the scFv-AP probe for MC detection.
Main Results:
- The developed scFv-AP immunoprobe specifically recognized a common motif shared by all microcystins.
- The direct competitive enzyme immunoassay enabled sensitive detection of MCs without the need for extensive purification steps.
- The recombinant antibody technology provided a robust and adaptable platform for MC detection.
Conclusions:
- Recombinant antibody technologies offer significant advantages over traditional chemical cross-linking methods for developing diagnostic tools.
- The scFv-AP fusion protein is a promising tool for the specific and efficient detection of microcystins in aquatic environments.
- This approach holds potential for in-situ water sample analysis and broader applications in toxin detection.

